Twist Bioscience Corp Quarterly Debt-to-equity in % from Q2 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Twist Bioscience Corp quarterly Debt-to-equity history and growth rate from Q2 2019 to Q3 2024.
  • Twist Bioscience Corp Debt-to-equity for the quarter ending September 30, 2024 was 27.2 %, a 19.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 27.2 +4.48 +19.8% Sep 30, 2024
Q2 2024 25.9 +3.81 +17.3% Jun 30, 2024
Q1 2024 24.3 +3.26 +15.5% Mar 31, 2024
Q4 2023 23.2 +2.97 +14.6% Dec 31, 2023
Q3 2023 22.7 +1.73 +8.26% Sep 30, 2023
Q2 2023 22 +1.33 +6.42% Jun 30, 2023
Q1 2023 21.1 +0.38 +1.84% Mar 31, 2023
Q4 2022 20.3 +1.39 +7.36% Dec 31, 2022
Q3 2022 21 +6.18 +41.8% Sep 30, 2022
Q2 2022 20.7 +6.96 +50.6% Jun 30, 2022
Q1 2022 20.7 +7.95 +62.4% Mar 31, 2022
Q4 2021 18.9 +3.56 +23.2% Dec 31, 2021
Q3 2021 14.8 -11 -42.6% Sep 30, 2021
Q2 2021 13.7 -14.3 -50.9% Jun 30, 2021
Q1 2021 12.7 -18.1 -58.8% Mar 31, 2021
Q4 2020 15.3 -17.5 -53.4% Dec 31, 2020
Q3 2020 25.7 +5.76 +28.8% Sep 30, 2020
Q2 2020 28 -19.3 -40.8% Jun 30, 2020
Q1 2020 30.9 Mar 31, 2020
Q4 2019 32.9 Dec 31, 2019
Q3 2019 20 Sep 30, 2019
Q2 2019 47.3 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.